Quantum
Home > Boards > US Listed > Biotechs > Dynavax Technologies Corp. (DVAX)

There's a whole lot to like going on

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
trebeg Member Profile
 
Followed By 13
Posts 1,727
Boards Moderated 0
Alias Born 01/30/07
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2018 4:29:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2018 4:11:27 PM
Dynavax Reports Third Quarter 2018 Financial Results, Progress on HEPLISAV-B Launch, and Updated SD-101 Data in Three Patient... GlobeNewswire Inc. - 11/5/2018 4:01:00 PM
Dynavax to Host Third Quarter 2018 Financial Results Conference Call GlobeNewswire Inc. - 10/29/2018 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2018 9:03:39 AM
Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab) Continues to Show a 70% Overall Response Rate in Advanced M... GlobeNewswire Inc. - 10/20/2018 8:45:00 AM
Dynavax Technologies and Quantum Leap Healthcare Collaborative Announce Selection of SD-101 Combined with KEYTRUDA® (pembrol... GlobeNewswire Inc. - 10/15/2018 6:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/11/2018 4:01:47 PM
Dynavax to Present New Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) at the European Society for Medical Onc... GlobeNewswire Inc. - 10/9/2018 6:00:00 AM
Dynavax to Present at the 2018 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/27/2018 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2018 4:13:09 PM
Dynavax Announces Publication of Preclinical Study of TLR9 Agonist in Lung Cancer GlobeNewswire Inc. - 9/4/2018 6:30:00 AM
Dynavax Announces Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 A... GlobeNewswire Inc. - 8/28/2018 6:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2018 4:55:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2018 4:54:04 PM
Dynavax Reports Second Quarter 2018 Financial Results GlobeNewswire Inc. - 8/6/2018 4:01:00 PM
Dynavax to Host Second Quarter 2018 Financial Results Conference Call GlobeNewswire Inc. - 7/30/2018 2:45:00 PM
Dynavax Appoints Scientific Advisory Board to Support its Oncology and Vaccine Programs GlobeNewswire Inc. - 6/28/2018 6:30:00 AM
Dynavax Presents Analysis of Data for Participants Aged 60 to 70 with Diabetes from its Phase 3 Trial of HEPLISAV-B® GlobeNewswire Inc. - 6/25/2018 12:05:00 PM
Dynavax to Present at the William Blair 38th Annual Growth Stock Conference GlobeNewswire Inc. - 6/11/2018 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2018 7:45:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2018 7:43:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2018 7:43:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2018 7:42:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2018 7:40:04 PM
trebeg   Thursday, 12/07/17 07:28:14 PM
Re: Banks post# 2189
Post # of 2312 
There's a whole lot to like going on with this company. Selling now would be a mistake IMO. The PPS should be higher and will go higher soon enough. I think you'd be kicking yourself in the you know where if you sold on this current dip. If anything it might be a good opportunity to add shares. I can see this hovering between 17-18, but not for much longer. All IMO. GLTA.

DVAX$$$$


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist